Let us take a look at three large pharma companies – ABBV, NVS and NVO – due to release their quarterly results on Feb 2.
Author archives: Indrajit Bandyopadhyay
5 Beaten-Down Biotech Bets to Bounce Back in 2022
Biotech stocks from the Medical sector, including APTO, CELU, CNSP, CYAD and SPRB, might be witnessing a turnaround in 2022 to emerge as solid investment options.